Drug Discovery & Development Presents: Pharma50Talks | Dr. Brad Perkins CMO at Karius
Welcome to Episode #2 of Pharma50Talks!
In this episode, Drug Discovery & Development Editor Brian Buntz, got a chance to sit down with Dr. Brad Perkins, Chief Medical Officer at Karius, who details how the company aims to transform the diagnosis of infections with a non-invasive #LiquidBiopsy. Dr. Perkins also talks about how the California startup aims to help establish a world where #InfectiousDisease is no longer a major human health threat.
Brad walks us through how Karius uses #Genomics and #AI to enable rapid accurate diagnosis of more than a 1,000 infectious pathogens from one test, how he has seen the demand for infectious disease #Diagnostics evolve, how AI based diagnostics can have a broader impact on our fight against antimicrobial resistance, and much more
Read the full story on how Karius aims to transform the diagnosis of infections with a non-invasive liquid biopsy, HERE: https://www.drugdiscoverytrends.com/h...
For more on 2022's #Pharma50, visit: https://www.drugdiscoverytrends.com/p...